| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |